CSX vs PROF · P/E 19, rev $14.09B vs rev $10.7M
CSX Corporation (CSX) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. PROF currently screens at market cap $238.7M.
Not investment advice. Open the CSX and PROF stock pages for the full models.
Not investment advice.